Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Velu

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Cancer Gene Therapy|April 19, 2000
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinaseC Grignet-Debrus, V Cool, N Baudson, et al.
Neuroreport|September 10, 2002
AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalonE Lehtonen, F Bonnaud, C Melas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Disseminated angiosarcoma presenting as a hemophagocytic syndrome in a renal allograft recipientJ L Dargent, P Vermylen, D Abramowicz, et al.
The British Journal of Ophthalmology|April 26, 2003
CXCR4 expression in vitreoretinal membranesL Cabay, F Willermain, C Bruyns, et al.
Journal of Leukocyte Biology|June 19, 2001
Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumorsM Toungouz, M Libin, F Bulté, et al.
Experimental Neurology|January 16, 2007
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vectorA Chtarto, X Yang, O Bockstael, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1993
Preferential activation of Th2 cells in chronic graft-versus-host reactionD De Wit, M Van Mechelen, C Zanin, et al.
Research in Immunology|December 16, 1998
Cellular vaccinesJ Bartholeyns, J L Romet-Lemonne, M Chokri, et al.
Human Gene Therapy|June 10, 1996
Gene therapy: socioeconomic and ethical issues. A roundtable discussionA L Hillman, M K Brenner, A L Caplan, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1997
Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovirG Stockhammer, J Brotchi, R Leblanc, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer Gene Therapy|April 19, 2000
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinaseC Grignet-Debrus, V Cool, N Baudson, et al.
Neuroreport|September 10, 2002
AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalonE Lehtonen, F Bonnaud, C Melas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Disseminated angiosarcoma presenting as a hemophagocytic syndrome in a renal allograft recipientJ L Dargent, P Vermylen, D Abramowicz, et al.
The British Journal of Ophthalmology|April 26, 2003
CXCR4 expression in vitreoretinal membranesL Cabay, F Willermain, C Bruyns, et al.
Journal of Leukocyte Biology|June 19, 2001
Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumorsM Toungouz, M Libin, F Bulté, et al.
Experimental Neurology|January 16, 2007
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vectorA Chtarto, X Yang, O Bockstael, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1993
Preferential activation of Th2 cells in chronic graft-versus-host reactionD De Wit, M Van Mechelen, C Zanin, et al.
Research in Immunology|December 16, 1998
Cellular vaccinesJ Bartholeyns, J L Romet-Lemonne, M Chokri, et al.
Human Gene Therapy|June 10, 1996
Gene therapy: socioeconomic and ethical issues. A roundtable discussionA L Hillman, M K Brenner, A L Caplan, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1997
Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovirG Stockhammer, J Brotchi, R Leblanc, et al.
Pageof 10